This natural product shows interesting activity against DYRK1A and a weak inhibition of CK1δ/ε (IC50 = 1.5 μM) as previously mentioned in various papers relating the use of harmine for treatment of neurodegenerative diseases [31,32]. This evidence concerns the gene DYRK1A and neurodegenerative disease.